Company Filing History:
Years Active: 2008
Title: **Innovative Contributions of Robert E. Waltermire in Spiro-Hydantoin Compounds**
Introduction
Robert E. Waltermire, an accomplished inventor based in Hillsborough, New Jersey, has made significant contributions to the field of medicinal chemistry. His innovative approach to spiro-hydantoin compounds has led to advancements in treatments for immune and inflammatory diseases, showcasing his expertise and commitment to research.
Latest Patents
Waltermire holds a patent for "Crystalline forms and process for preparing spiro-hydantoin compounds." This innovative process involves preparing spiro-hydantoin compounds defined by a complex formula, with various subcomponents that include enantiomeric separation techniques to produce specific enantiomers of these compounds. The result is not only useful variations of the spiro-hydantoin compounds but also novel products aimed at addressing crucial medicinal needs.
Career Highlights
Robert E. Waltermire has had a notable career at Bristol-Myers Squibb Company, a leading global biopharmaceutical firm. His work emphasizes the importance of pharmaceutical innovation, as evidenced by the patent he developed, which positions him as a key figure in advancing therapeutic agents for challenging health conditions.
Collaborations
Throughout his career, Waltermire has collaborated with talented colleagues, including Albert J. DelMonte and T. G. Murali Dhar. These partnerships have allowed for a synergistic exchange of ideas and expertise, reinforcing the collaborative nature of pharmaceutical research and development.
Conclusion
Robert E. Waltermire's work exemplifies the essence of innovation in the health sciences. With his patent on spiro-hydantoin compounds, he has contributed towards developing effective treatments for immune and inflammatory diseases, marking him as a noteworthy inventor in the pharmaceutical industry. His dedication to advancement in medicinal chemistry continues to inspire future innovations in the field.